Siegfried Muhlack

St. Josef Hospital
Bochum, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

User groups of inpatient multidisciplinary therapies for Parkinson's disease in Germany: a bicenter prospective observational study.

User groups of inpatient multidisciplinary therapies for Parkinson's disease in Germany: a bicenter prospective observational study.

Journal: Neurological research and practice

Published: April 23, 2025

Longitudinal evaluation of polyneuropathy in Parkinson's disease.

Longitudinal evaluation of polyneuropathy in Parkinson's disease.

Journal: Journal of neurology

Published: May 18, 2024

COVID-19 outcomes in hospitalized Parkinson's disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany.

COVID-19 outcomes in hospitalized Parkinson's disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany.

Journal: Neurological research and practice

Published: April 01, 2022

Parkinson's Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement.

Parkinson's Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement.

Journal: Journal of clinical medicine

Published: May 11, 2020

Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.

Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.

Journal: Journal of neurology

Published: October 08, 2019

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.

Journal: Cells

Published: December 31, 2018

Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010⁻2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers.

Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010⁻2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers.

Journal: Cells

Published: December 27, 2018

Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease.

Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease.

Journal: Cells

Published: December 20, 2018

Emerging Immunotherapies for Parkinson Disease.

Emerging Immunotherapies for Parkinson Disease.

Journal: Neurology and therapy

Published: October 12, 2018

Characteristics and dynamics of inpatient treatment of patients with Parkinson's disease in Germany : Analysis of 1.5 million patient cases from 2010 to 2015

Characteristics and dynamics of inpatient treatment of patients with Parkinson's disease in Germany : Analysis of 1.5 million patient cases from 2010 to 2015

Journal: Der Nervenarzt

Published: August 08, 2018

Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients.

Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients.

Journal: Frontiers in neurology

Published: May 19, 2018

Association of exposure to manganese and iron with striatal and thalamic GABA and other neurometabolites - Neuroimaging results from the WELDOX II study.

Association of exposure to manganese and iron with striatal and thalamic GABA and other neurometabolites - Neuroimaging results from the WELDOX II study.

Journal: Neurotoxicology

Published: April 27, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026